What pre‑procedure evaluation is required for a patient being considered for a transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites or recurrent variceal hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pre-Procedure TIPS Patient Assessment

For elective TIPS, obtain contrast-enhanced multiphasic cross-sectional imaging (CT or MRI) and comprehensive echocardiography; for emergent TIPS, at minimum perform liver ultrasound with Doppler and consider bedside echocardiogram. 1

Essential Pre-Procedure Imaging

Elective TIPS Setting

  • Contrast-enhanced multiphasic CT or MRI to evaluate portal venous anatomy, assess for portal vein thrombosis, identify hepatic lesions/cysts that could preclude TIPS creation, and assist with procedural planning 1
  • Comprehensive echocardiography to assess:
    • Left ventricular ejection fraction and cardiac structure
    • Right ventricular systolic pressure
    • Valvular heart disease severity
    • Overall cardiac function 1

Emergent TIPS Setting

When time is limited, clinical judgment should guide the workup, but at minimum obtain:

  • Liver ultrasound with Doppler to evaluate portal venous system patency
  • Limited (bedside) echocardiogram focusing on left ventricular ejection fraction and right ventricular systolic pressure 1

Clinical Assessment and Risk Stratification

Multidisciplinary Evaluation

Rather than relying on absolute MELD cutoffs, use a multidisciplinary approach involving Gastroenterology/Hepatology, Cardiology, Pulmonary, and potentially Nephrology and Critical Care to assess TIPS candidacy 1. This is particularly important for:

  • Patients requiring higher levels of care
  • Potential liver transplant candidates
  • Patients with extensive portal vein thrombosis requiring specialized IR expertise 1

Absolute Contraindications to Screen For

The pre-procedure assessment must identify these absolute contraindications 1:

Cardiac:

  • Severe congestive heart failure (ACC/AHA Stage C or D)
  • Severe untreated valvular heart disease (AHA/ACC stage C or D)
  • Moderate-severe pulmonary hypertension (based on invasive measurements) despite medical optimization

Hepatic:

  • Refractory overt hepatic encephalopathy
  • Unrelieved biliary obstruction
  • Hepatic lesions (cysts) or tumors in the liver parenchyma that preclude TIPS creation

Systemic:

  • Uncontrolled systemic infection

Laboratory Assessment

While specific thresholds are not definitively established, baseline laboratory evaluation should include:

  • Complete blood count
  • Coagulation parameters (INR, though no specific target INR is recommended for correction) 1
  • Comprehensive metabolic panel including liver function tests
  • MELD score calculation for risk stratification 1

Important caveat: There is insufficient evidence to recommend specific target INR or platelet thresholds prior to TIPS placement 1. The decision to correct coagulopathy should be individualized based on patient and procedural factors.

Liver Transplant Evaluation Consideration

There is insufficient evidence to recommend universal pre-procedure liver transplant evaluation for all patients undergoing elective or emergent TIPS 1. However, in patients who may be transplant candidates or those with advanced liver disease, referral to centers with transplant expertise should be considered.

Common Pitfalls to Avoid

  • Don't skip cardiac evaluation in elective cases: Cardiac complications post-TIPS can be catastrophic. Comprehensive echocardiography is essential, not optional 1
  • Don't delay emergent TIPS for extensive workup: In acute variceal bleeding, limited but focused assessment (Doppler ultrasound and bedside echo) is acceptable 1
  • Don't rely solely on MELD score: A multidisciplinary assessment considering overall clinical status, cardiac function, and hepatic reserve is superior to any single cutoff 1
  • Don't overlook anatomical barriers: Cross-sectional imaging may reveal portal vein thrombosis, hepatic lesions, or anatomical variants that could make TIPS technically impossible or contraindicated 1

The most recent 2025 EASL guidelines 2 emphasize post-procedural monitoring but defer to the comprehensive 2022 North American recommendations 1 for pre-procedure assessment, which provide the most detailed and evidence-based framework for patient evaluation.

References

2
Guideline

easl clinical practice guidelines on tips.

Journal of Hepatology, 2025

Related Questions

What is the drug of choice to reduce acute esophageal variceal bleeding?
What are the indications for Transjugular Intrahepatic Portosystemic Shunt (TIPS)?
What is the first-line antibiotic for a cirrhotic patient with suspected variceal bleeding presenting with hematemesis?
Should metronidazole be added to ceftriaxone prophylaxis in a patient with variceal bleeding?
How should acute variceal bleeding be managed?
What are the key components of a pre‑procedure assessment for a pediatric patient, including history, physical examination, fasting verification, airway and cardiopulmonary evaluation, and necessary laboratory tests?
What is Dravet syndrome?
What is the recommended evaluation and management for a suspected page kidney causing new‑onset hypertension in an adult after trauma, surgery, or renal biopsy?
Is a regimen of nebivolol 5 mg and valsartan 80 mg in the morning plus amlodipine 5 mg and valsartan 80 mg at night an appropriate combination therapy for a patient whose untreated systolic blood pressure reaches 177 mm Hg?
What are the causes of Page kidney syndrome in an adult with new‑onset hypertension following trauma, surgery, or renal biopsy?
What is the recommended insulin dosing for an adult with hyperglycemia (random plasma glucose ≥250 mg/dL)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question